Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/30/2025

ICD‑10 Coding Guidelines for Asymptomatic STD Screening (Z11.3)

  • Sexually active females younger than 25 years should receive annual chlamydia and gonorrhea screening coded with Z11.3. (CDC MMWR recommendation) [1][2]
  • Sexually active males in settings where STD prevalence is ≥ 2 % should be screened routinely and coded with Z11.3. (CDC MMWR recommendation) 2
  • Individuals entering correctional or detention facilities should be screened for syphilis, gonorrhea, and chlamydia within the first 24 hours, using Z11.3. (CDC MMWR recommendation) 3
  • Adolescents in institutional settings (e.g., schools, community programs) should be screened when local prevalence is ≥ 2 %, with encounters coded Z11.3. (CDC MMWR recommendation) 3
  • People living with HIV who are sexually active should undergo regular STD screening coded with Z11.3. (CDC MMWR & IDSA guideline) [4][2]
  • Women older than 25 years with risk factors (e.g., new or multiple partners, partner with concurrent partners) should be screened annually using Z11.3. (CDC MMWR recommendation) 1
  • Men who have sex with men (MSM) should receive site‑specific annual screening coded with Z11.3. (CDC MMWR & IDSA guideline) [1][4]
  • Persons with a prior history of an STD should be screened at least once per year, coding the encounter with Z11.3. (IDSA guideline) 4

Situations Where Z11.3 Must NOT Be Used

  • Symptomatic presentations (e.g., urethral discharge, dysuria, genital lesions, pelvic pain) require symptom‑ or disease‑specific codes, not Z11.3. (CDC MMWR recommendation) [1][3]
  • Pap (cervical cancer) screening is not an STD screening activity and should never be coded with Z11.3. (CDC MMWR recommendations) [5][6]7
  • HPV DNA testing performed as part of cervical cancer screening is also excluded from Z11.3 coding. (CDC MMWR recommendations) [5][7]

Follow‑Up and Retesting Coding

  • Three‑month retesting after a positive chlamydia or gonorrhea result—if the patient is asymptomatic—should continue to be coded with Z11.3, reflecting screening for reinfection. (CDC MMWR & IDSA guideline) [1][4]
  • Annual screening encounters in high‑risk populations must consistently use Z11.3 for each preventive visit. (CDC MMWR & IDSA guideline) [1][4]

Algorithmic Decision Points (Summarized)

  • Asymptomatic patient? → Use Z11.3 for routine screening. (CDC MMWR recommendation) 1
  • Known exposure to an infected partner? → Use Z20.2 (contact/exposure) instead of Z11.3. (CDC MMWR recommendation) 2
  • Known HIV exposure? → Use Z20.6 (HIV exposure) rather than Z11.3. (CDC MMWR recommendation) 2
  • Encounter is for Pap or HPV cervical cancer screening? → Apply cervical‑screening codes, not Z11.3. (CDC MMWR recommendation) 6

STD Screening Guidelines

Primary Screening Codes

  • The Centers for Disease Control and Prevention recommends using ICD-10 code Z11.3 for encounters specifically for screening for sexually transmitted infections in asymptomatic patients, as stated in the MMWR Recommendations and Reports 8, 9

Screening Recommendations by Population

  • The Centers for Disease Control and Prevention recommends that all sexually active females aged less than 25 years should be screened for chlamydia and gonorrhea at least annually, coded with Z11.3 9
  • The Centers for Disease Control and Prevention recommends that young sexually active men should be screened routinely, particularly in settings where prevalence is greater than or equal to 2%, coded with Z11.3 9
  • The Centers for Disease Control and Prevention recommends that persons entering correctional facilities should be screened for syphilis, gonorrhea, and chlamydia, coded with Z11.3 10
  • The Centers for Disease Control and Prevention recommends that adolescents in institutional settings should be screened when prevalence is greater than or equal to 2%, coded with Z11.3 10

Common Coding Pitfalls to Avoid

  • The Centers for Disease Control and Prevention explicitly states that Pap tests should not be considered screening tests for STDs, as reported in the MMWR Recommendations and Reports 11, 12

REFERENCES